Selected research
Industry Research
Ketamine Hydrochloride Industry Research Report 2026
Market perspective
The global Ketamine Hydrochloride market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ketamine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ketamine Hydrochloride is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ketamine Hydrochloride is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ketamine Hydrochloride include AuroMedics, Dechra, Dephis Pharma, Evonik, Fine Organics, Gedeon Richter, LGC Group, Midas Pharma and Seqens, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ketamine Hydrochloride market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ketamine Hydrochloride Market by Company
AuroMedics
Dechra
Dephis Pharma
Evonik
Fine Organics
Gedeon Richter
LGC Group
Midas Pharma
Seqens
Spectrum Chemical
Pfizer
Jiangsu Bucolic
Ketamine Hydrochloride Segment by Type
Tablet
Solution
Powder
Ketamine Hydrochloride Segment by Application
Hospital
Animals Health
Others
Ketamine Hydrochloride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketamine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ketamine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketamine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ketamine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ketamine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ketamine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Solution
- Powder
Applications
- Hospital
- Animals Health
- Others
Companies covered
- AuroMedics
- Dechra
- Dephis Pharma
- Evonik
- Fine Organics
- Gedeon Richter
- LGC Group
- Midas Pharma
- Seqens
- Spectrum Chemical
- Pfizer
- Jiangsu Bucolic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ketamine Hydrochloride Market Size (2021-2032)
- 2.2.2 Global Ketamine Hydrochloride Sales (2021-2032)
- 2.2.3 Global Ketamine Hydrochloride Market Average Price (2021-2032)
- 2.3 Ketamine Hydrochloride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Solution
- 2.3.4 Powder
- 2.4 Ketamine Hydrochloride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Animals Health
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ketamine Hydrochloride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ketamine Hydrochloride Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Ketamine Hydrochloride Revenue of Manufacturers (2021-2026)
- 3.4 Global Ketamine Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.5 Global Ketamine Hydrochloride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ketamine Hydrochloride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ketamine Hydrochloride, Product Type & Application
- 3.8 Global Manufacturers of Ketamine Hydrochloride, Established Date
- 3.9 Global Ketamine Hydrochloride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AuroMedics
- 4.1.1 AuroMedics Company Information
- 4.1.2 AuroMedics Business Overview
- 4.1.3 AuroMedics Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AuroMedics Ketamine Hydrochloride Product Portfolio
- 4.1.5 AuroMedics Recent Developments
- 4.2 Dechra
- 4.2.1 Dechra Company Information
- 4.2.2 Dechra Business Overview
- 4.2.3 Dechra Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dechra Ketamine Hydrochloride Product Portfolio
- 4.2.5 Dechra Recent Developments
- 4.3 Dephis Pharma
- 4.3.1 Dephis Pharma Company Information
- 4.3.2 Dephis Pharma Business Overview
- 4.3.3 Dephis Pharma Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dephis Pharma Ketamine Hydrochloride Product Portfolio
- 4.3.5 Dephis Pharma Recent Developments
- 4.4 Evonik
- 4.4.1 Evonik Company Information
- 4.4.2 Evonik Business Overview
- 4.4.3 Evonik Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Evonik Ketamine Hydrochloride Product Portfolio
- 4.4.5 Evonik Recent Developments
- 4.5 Fine Organics
- 4.5.1 Fine Organics Company Information
- 4.5.2 Fine Organics Business Overview
- 4.5.3 Fine Organics Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fine Organics Ketamine Hydrochloride Product Portfolio
- 4.5.5 Fine Organics Recent Developments
- 4.6 Gedeon Richter
- 4.6.1 Gedeon Richter Company Information
- 4.6.2 Gedeon Richter Business Overview
- 4.6.3 Gedeon Richter Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Gedeon Richter Ketamine Hydrochloride Product Portfolio
- 4.6.5 Gedeon Richter Recent Developments
- 4.7 LGC Group
- 4.7.1 LGC Group Company Information
- 4.7.2 LGC Group Business Overview
- 4.7.3 LGC Group Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LGC Group Ketamine Hydrochloride Product Portfolio
- 4.7.5 LGC Group Recent Developments
- 4.8 Midas Pharma
- 4.8.1 Midas Pharma Company Information
- 4.8.2 Midas Pharma Business Overview
- 4.8.3 Midas Pharma Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Midas Pharma Ketamine Hydrochloride Product Portfolio
- 4.8.5 Midas Pharma Recent Developments
- 4.9 Seqens
- 4.9.1 Seqens Company Information
- 4.9.2 Seqens Business Overview
- 4.9.3 Seqens Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Seqens Ketamine Hydrochloride Product Portfolio
- 4.9.5 Seqens Recent Developments
- 4.10 Spectrum Chemical
- 4.10.1 Spectrum Chemical Company Information
- 4.10.2 Spectrum Chemical Business Overview
- 4.10.3 Spectrum Chemical Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Spectrum Chemical Ketamine Hydrochloride Product Portfolio
- 4.10.5 Spectrum Chemical Recent Developments
- 4.11 Pfizer
- 4.11.1 Pfizer Company Information
- 4.11.2 Pfizer Business Overview
- 4.11.3 Pfizer Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Pfizer Ketamine Hydrochloride Product Portfolio
- 4.11.5 Pfizer Recent Developments
- 4.12 Jiangsu Bucolic
- 4.12.1 Jiangsu Bucolic Company Information
- 4.12.2 Jiangsu Bucolic Business Overview
- 4.12.3 Jiangsu Bucolic Ketamine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Jiangsu Bucolic Ketamine Hydrochloride Product Portfolio
- 4.12.5 Jiangsu Bucolic Recent Developments
5 Global Ketamine Hydrochloride Market Scenario by Region
- 5.1 Global Ketamine Hydrochloride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ketamine Hydrochloride Sales by Region: 2021-2032
- 5.2.1 Global Ketamine Hydrochloride Sales by Region: 2021-2026
- 5.2.2 Global Ketamine Hydrochloride Sales by Region: 2027-2032
- 5.3 Global Ketamine Hydrochloride Revenue by Region: 2021-2032
- 5.3.1 Global Ketamine Hydrochloride Revenue by Region: 2021-2026
- 5.3.2 Global Ketamine Hydrochloride Revenue by Region: 2027-2032
- 5.4 North America Ketamine Hydrochloride Market Facts & Figures by Country
- 5.4.1 North America Ketamine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ketamine Hydrochloride Sales by Country (2021-2032)
- 5.4.3 North America Ketamine Hydrochloride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ketamine Hydrochloride Market Facts & Figures by Country
- 5.5.1 Europe Ketamine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ketamine Hydrochloride Sales by Country (2021-2032)
- 5.5.3 Europe Ketamine Hydrochloride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Ketamine Hydrochloride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ketamine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ketamine Hydrochloride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ketamine Hydrochloride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ketamine Hydrochloride Market Facts & Figures by Country
- 5.7.1 South America Ketamine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ketamine Hydrochloride Sales by Country (2021-2032)
- 5.7.3 South America Ketamine Hydrochloride Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Ketamine Hydrochloride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ketamine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ketamine Hydrochloride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ketamine Hydrochloride Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ketamine Hydrochloride Sales by Type (2021-2032)
- 6.1.1 Global Ketamine Hydrochloride Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Ketamine Hydrochloride Sales Market Share by Type (2021-2032)
- 6.2 Global Ketamine Hydrochloride Revenue by Type (2021-2032)
- 6.2.1 Global Ketamine Hydrochloride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ketamine Hydrochloride Revenue Market Share by Type (2021-2032)
- 6.3 Global Ketamine Hydrochloride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ketamine Hydrochloride Sales by Application (2021-2032)
- 7.1.1 Global Ketamine Hydrochloride Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Ketamine Hydrochloride Sales Market Share by Application (2021-2032)
- 7.2 Global Ketamine Hydrochloride Revenue by Application (2021-2032)
- 7.2.1 Global Ketamine Hydrochloride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ketamine Hydrochloride Revenue Market Share by Application (2021-2032)
- 7.3 Global Ketamine Hydrochloride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ketamine Hydrochloride Value Chain Analysis
- 8.1.1 Ketamine Hydrochloride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ketamine Hydrochloride Production Mode & Process
- 8.2 Ketamine Hydrochloride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ketamine Hydrochloride Distributors
- 8.2.3 Ketamine Hydrochloride Customers
9 Global Ketamine Hydrochloride Analyzing Market Dynamics
- 9.1 Ketamine Hydrochloride Industry Trends
- 9.2 Ketamine Hydrochloride Industry Drivers
- 9.3 Ketamine Hydrochloride Industry Opportunities and Challenges
- 9.4 Ketamine Hydrochloride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst